Perrigo Company plc (PRGO)

USD 25.44

(-3.67%)

Total Assets Summary of Perrigo Company plc

  • Perrigo Company plc's latest annual total assets in 2023 was 10.8 Billion USD , down -1.89% from previous year.
  • Perrigo Company plc's latest quarterly total assets in 2024 Q2 was 10.39 Billion USD , down -2.28% from previous quarter.
  • Perrigo Company plc reported annual total assets of 11.01 Billion USD in 2022, up 5.67% from previous year.
  • Perrigo Company plc reported annual total assets of 10.42 Billion USD in 2021, down -9.25% from previous year.
  • Perrigo Company plc reported quarterly total assets of 10.39 Billion USD for 2024 Q2, down -2.28% from previous quarter.
  • Perrigo Company plc reported quarterly total assets of 10.95 Billion USD for 2023 Q1, down -0.57% from previous quarter.

Annual Total Assets Chart of Perrigo Company plc (2023 - 1992)

Historical Annual Total Assets of Perrigo Company plc (2023 - 1992)

Year Total Assets Total Assets Growth
2023 10.8 Billion USD -1.89%
2022 11.01 Billion USD 5.67%
2021 10.42 Billion USD -9.25%
2020 11.48 Billion USD 1.65%
2019 11.3 Billion USD 2.9%
2018 10.98 Billion USD -5.55%
2017 11.62 Billion USD -16.16%
2016 13.87 Billion USD -29.67%
2015 19.72 Billion USD 42.08%
2014 13.88 Billion USD 159.4%
2013 5.35 Billion USD 32.97%
2012 4.02 Billion USD 26.18%
2011 3.18 Billion USD 3.12%
2010 3.09 Billion USD 21.94%
2009 2.53 Billion USD -1.5%
2008 2.57 Billion USD 33.76%
2007 1.92 Billion USD 9.97%
2006 1.75 Billion USD 2.68%
2005 1.7 Billion USD 124.61%
2004 759.09 Million USD 17.88%
2003 643.97 Million USD 8.45%
2002 593.78 Million USD 3.1%
2001 575.91 Million USD 18.48%
2000 486.06 Million USD -21.08%
1999 615.9 Million USD 3.36%
1998 595.9 Million USD 4.84%
1997 568.4 Million USD 3.46%
1996 549.4 Million USD -1.13%
1995 555.7 Million USD 16.99%
1994 475 Million USD 14.82%
1993 413.7 Million USD 30.55%
1992 316.9 Million USD 0.0%

Peer Total Assets Comparison of Perrigo Company plc

Name Total Assets Total Assets Difference
Amneal Pharmaceuticals, Inc. 3.47 Billion USD -211.271%
Bausch Health Companies Inc. 27.35 Billion USD 60.479%
Catalent, Inc. 9.75 Billion USD -10.828%
Emergent BioSolutions Inc. 1.83 Billion USD -489.084%
Elanco Animal Health Incorporated 14.36 Billion USD 24.738%
Teva Pharmaceutical Industries Limited 43.47 Billion USD 75.139%
Zoetis Inc. 14.28 Billion USD 24.338%